ArticlePharmaceuticals (Basel, Switzerland)2026
Cardiovascular Risks of COVID-19 Therapeutics: Integrated Analysis of FAERS, Electronic Health Records, and Transcriptomics.
Xinran Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.